ArticleBlood2018

A CD19/CD3 bispecific antibody for effective immunotherapy of chronic lymphocytic leukemia in the ibrutinib era.

Hannah R Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.